Shares of Allergan plc. (NYSE:AGN) declined -2.19% and ended at $236.39 smaller than previous closing price of $241.69. The total 3.67 million shares were bought and sold throughout the most recent trading session more than average volume of 3 million shares.
Currently Allergan plc. (AGN) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “17″ Analysts”. “0” rated “Sell” for the company. “3” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $303.61 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $400.00 however minimum price target advised by analysts is $227.00. The Median price target for the stock is measured at $300.00.
Presently, Analysts decided consensus EPS estimate of $3.65 for present quarter and one month ago projected EPS estimate was at $3.63. If we take a look at back 3 month ago, consensus EPS estimate was $3.61.
A current consensus EPS estimate for next quarter is at $4.07 and 3 month ago EPS forecast was $4.06. Have a look at back 1 month ago, consensus EPS forecast was seen at $4.04.
For current fiscal year, most recent EPS estimate is set at $14.09 based on Analyst consensus and three month ago consensus EPS opinions was at $14.18. During period one month ago, consensus EPS forecast was decided at $14.08.
A current consensus EPS projection for next fiscal year is observed at $17.17 and one month ago consensus EPS forecast was at $17.21. Take a look at back three month ago, consensus EPS estimate opinions was decided at $17.32 by analysts.
One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 16 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 3. 4 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 15 said a “Buy Rating” and 3 announced “Overweight Rating”. 4 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.